Multidisciplinary Expert Reviews
Overview
Diligent reviews are conducted by a team of senior executives with synergistic competencies and experiences in:
- Pre-clinical / clinical development
- Biotech / pharma environment
- Broad range of therapeutic areas’
Our purpose is to assist decision makers from financial, pharmaceutical, biotech and public sectors by providing independent and comprehensive reviews of health technologies, strategies and product development pipelines with the highest level of scientific rigor, integrity and timely delivery.
Summary
- Reviews are conducted in accordance with the specific needs and values of each client and are designed to seamlessly integrate established internal workflows.
- Potential projects include:
- Evaluation of investment opportunities
- Scientific due diligence
- Assessment of acquisition and merger targets
- Evaluation of in- and out-licensing opportunities
- Preparation/coaching for due diligence and financing rounds
- Optimization of drug development strategies and milestones
- Review and design of development plans
- Reports for Board of directors and senior management for good corporate governance
- Regular follow-up of program advancement
- External validation and assistance to management
- Competitive intelligence and landscape
- A dedicated and reliable senior team with:
- Over 40 years of cumulative experience in pharmaceutical development
- In-depth knowledge of biotech, pharmaceutical and venture capital sectors
- Complementary expertise in pre-clinical and clinical development
- Product development know-how at various stages
- Broad experience in many therapeutic areas including biologics, cardiology, immunology, infectious diseases, metabolic disorders, oncology, pain, pulmonary diseases, therapeutic vaccines and virology
- Thorough understanding of intellectual property and patent strategies
- Experience in conducting jointed due diligence reviews
